• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
YUAN Tengteng,WANG Lei,TANG Yanan,HU Zihan,DU Jiaojiao,WANG Rulin,ZHANG Caiyun,CHEN Weidong.Research progress on pharmacological action and new dosage forms of paeoniflorin[J].Journal Of Pharmaceutical Research,2022,41(12):808-814[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2205times   Download 2867次 QR Code for this article
Scan with your phone!
芍药苷保肝药理作用及新剂型的研究进展
袁腾腾1,2,3,王雷1,2,唐亚楠1,2,3,胡子晗1,2,3,杜娇娇1,2,3,王汝琳1,2,张彩云1,2,3,陈卫东1,2
Font:Larger+|Default|Smaller-
(1.安徽中医药大学药学院,安徽 合肥 230012;2.中药复方安徽省重点实验室,安徽 合肥 230012;3.现代药物制剂安徽省工程技术研究中心,安徽 合肥 230038)
摘要:
芍药苷是一种单萜糖苷类化合物,其保肝药理活性显著。但芍药苷的脂溶性差导致生物利用度低,起效较慢,限制了其广泛应用,研究和开发芍药苷新剂型以提高生物利用度和药效是当前研究的热点。基于此,本文综合国内外相关文献,对芍药苷保肝药理作用和新剂型的研究进行全面的整理综述,以期为芍药苷的应用和新剂型研发提供理论依据和思路参考。
关键词:  芍药苷  保肝  药理作用  新剂型
DOI:10.13506/j.cnki.jpr.2022.12.008
基金项目:国家自然科学基金项目(No.51303006、82104517);安徽省教育厅基金项目(No.KJ2021ZD0065);安徽省重大专项(No.202203a07020031);省级大学生创新创业项目(No.S202110369017)
Publication Date:December 25, 2022
Research progress on pharmacological action and new dosage forms of paeoniflorin
YUAN Tengteng1,2,3,WANG Lei1,2,TANG Yanan1,2,3,HU Zihan1,2,3,DU Jiaojiao1,2,3,WANG Rulin1,2,ZHANG Caiyun1,2,3,CHEN Weidong1,2
(1. School of Pharmacy,Anhui University of Chinese Medicine,Hefei 230012, China;2.Anhui Province Key Laboratory of Chinese Medicinal Formula,Hefei 230012,China;3.Engineering Technology Research Center of Modern Pharmaceutical Preparation, Hefei 230038, China)
Abstract:
Paeoniflorin is a monoterpene glycoside compound with remarkable hepatoprotective activity. However, the poor lipid solubility of paeoniflorin leads to low bioavailability and slow onset of action, which limits its wide application. Therefore, the research and development of new dosage forms of paeoniflorin to improve the bioavailability and drug efficacy is a hotspot of current research. Based on this, this article synthesizes relevant domestic and foreign literatures, and performs a comprehensive and collated review of the research on the hepatoprotective pharmacological effects and new dosage forms of paeoniflorin, with a view to providing theoretical basis and ideas for the application and new dosage forms development reference.
Key words:  Paeoniflorin  Liver protection  Pharmacological action  New dosage forms
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.